International – New restrictions for AZ/Oxford COVID-19 vaccine despite EMA endorsement

Regulators in Canada and Germany have reportedly restricted the use of AstraZeneca (AZ) and Oxford University’s COVID-19 vaccine in certain age groups, despite the European Medicines Agency (EMA) reconfirming the safety of the jab.

The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) met yesterday as part of an ongoing review into ‘very rare’ cases of blood clots with low numbers of platelets in people vaccinated with the AZ/Oxford vaccine – which has now been given the brand name Vaxzevria in the EU.

The EU regulator said that the review has currently not identified any specific risk factors, including age, gender or previous medical history of clotting disorders for the very rare blood clot events.

‘A causal link with the vaccine is not proven, but is possible and further analysis is continuing,’ added the EMA…